Value Stocks a Week Away From ‘Holy Grail’ Momentum Boost

Urgent Buy Alert: FDA Just OK'd Massive Biotech Breakthrough A few years back analyst Jeff Siegel told me to buy Canopy Growth Corp and I sat on his advice. The stock soared from $1.40 a share to $49 a share - a gain of 3,043% -- I really blew it!  Now Jeff has found a brand-new opportunity (not cannabis) the FDA has already given the green light to that he thinks could be 10x bigger. [ad] Get the details in this FREE report. Seattle company's cannabis candies could fuel boom in stock shares A popular Seattle cannabis manufacturer recently announced the roll-out of an all-new line of premium infused edibles, marketed under the brand name "Goodies."  Hand-crafted, gluten-free and using all-natural ingredients, the candies and caramels contain micro-dose servings of just 5-mg THC for a controlled, measured experience. [ad] Get a FREE report on new pot stock blockbuster This $4 Stock is the Key to the next Tech Revolution One little-known $4 stock holds the key to a massive tech breakthrough, but 99.9% of investors have never heard of it. My research says we are just weeks away from big news on this front being announced. [ad] If you move before this news breaks, this could hand you 1,000% gains or more. See the details here. The FDA has already given the green light...Click HERE Value Stocks a Week Away From 'Holy Grail' Momentum Boost "There is a significant overlap emerging between deep value stocks and momentum stocks — there are a number of autos, banks, materials, and energy stocks which are screening as both value and momentum," wrote Bernstein strategist Sarah McCarthy DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.

2563 cherry hill ln, hermitage, PA 16148, United States You may unsubscribe or change your contact details at any time. Powered by: